Talking throughout a roundtable occasion in London final week, Main stated Trump would possible take a softer stance on antitrust regulation, permitting for extra mergers and acquisitions within the healthcare sector, and has refused to argue in favour of curbing entitlement programmes.
“Below a Trump presidency, there could possibly be extra pleasure and urge for food for M&A exercise involving potential targets amongst small or mid-cap biotechs and healthcare programmes,” he stated. “This might drive out efficiency on this phase relative to massive or mega-cap corporations.”
Regardless of this, the Bellevue fund supervisor …
